Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
- Variant table
- Variant image
- Structural variants
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: Tnfsf15 ENSRNOG00000008930

.

Description

TNF superfamily member 15 [Source:RGD Symbol;Acc:628735]

Gene Synonyms

Tnlg1b

Location

Primary_assembly 5: 82,150,376-82,171,882 reverse strand.

GRCr8:CM070395.1

About this gene

This gene has 3 transcripts (splice variants), 122 orthologues, 8 paralogues and is associated with 8 phenotypes.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSRNOT00000162272.1	Tnfsf15-203	6226	270aa	ENSRNOP00000104629.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical,
ENSRNOT00000134411.1	Tnfsf15-202	5970	251aa	ENSRNOP00000104566.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	-
ENSRNOT00000011845.5	Tnfsf15-201	1858	257aa	ENSRNOP00000011845.4	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A0H2UHG9	APPRIS P2: Where the APPRIS core modules are unable to choose a clear principal variant (approximately 25% of human protein coding genes), the database chooses two or more of the CDS variants as "candidates" to be the principal variant. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P2,

.

Summary

.

.